Drug delivery and translational research
Dynamic 3D microfluidic platform for exploring combined targeted therapy, chemotherapy, and virotherapy delivery in ovarian cancer.
Lukasz Kuryk, Sara Mathlouthi, Lisa Casagrande, Cristiano Pesce, Francesco Tognetti, Alessio Malfanti, Aleksander Masny, Paolo Caliceti, Mariangela Garofalo
Published: 202510.1007/s13346-025-01997-4
Abstract
Ovarian cancer poses a persistent therapeutic challenge due to late-stage diagnosis, frequent relapse, and resistance to standard therapies. While oncolytic viruses (OVs) offer a promising immunotherapeutic approach, their clinical efficacy remains l…
Preview only. Read the full abstract at the source